Northern Trust’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Northern Trust’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,093,646	Closed	-$20.4M	–	4837
2022 Q1	$20.4M	Sell	1,093,646 -47,289	-4%	-$851K	﹤0.01%	1658
2021 Q4	$24.4M	Buy	1,140,935 +56,435	+5%	+$1.11M	﹤0.01%	1629
2021 Q3	$20M	Buy	1,084,500 +151,216	+16%	+$3.04M	﹤0.01%	1812
2021 Q2	$20M	Buy	933,284 +8,068	+0.9%	+$164K	﹤0.01%	1880
2021 Q1	$17.9M	Buy	+925,216	New	+$16.3M	﹤0.01%	1907

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northern Trust's OCDX Position: Q2 2022 in Review

Northern Trust sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 1,093,646 shares — an estimated $20.4M sold.

Northern Trust first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $24.4M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Northern Trust reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Northern Trust sold 1,093,646 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $20.4M.
Northern Trust first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Northern Trust's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $24.4M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.